Zydus Lifesciences’ anaemia drug Desidustat gets China approval
China’s drug regulator, the NMPA, has approved a treatment for renal anaemia in adult CKD patients not on dialysis
China’s drug regulator, the NMPA, has approved a treatment for renal anaemia in adult CKD patients not on dialysis